JPWO2022248478A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022248478A5 JPWO2022248478A5 JP2023571866A JP2023571866A JPWO2022248478A5 JP WO2022248478 A5 JPWO2022248478 A5 JP WO2022248478A5 JP 2023571866 A JP2023571866 A JP 2023571866A JP 2023571866 A JP2023571866 A JP 2023571866A JP WO2022248478 A5 JPWO2022248478 A5 JP WO2022248478A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163192217P | 2021-05-24 | 2021-05-24 | |
| US63/192,217 | 2021-05-24 | ||
| PCT/EP2022/064061 WO2022248478A1 (en) | 2021-05-24 | 2022-05-24 | Compositions and methods for treating lung cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024521105A JP2024521105A (ja) | 2024-05-28 |
| JP2024521105A5 JP2024521105A5 (https=) | 2025-06-03 |
| JPWO2022248478A5 true JPWO2022248478A5 (https=) | 2025-06-03 |
Family
ID=82100132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571866A Pending JP2024521105A (ja) | 2021-05-24 | 2022-05-24 | 肺癌の処置用組成物及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240254235A1 (https=) |
| EP (1) | EP4347038A1 (https=) |
| JP (1) | JP2024521105A (https=) |
| KR (1) | KR20240012413A (https=) |
| CN (1) | CN117425493A (https=) |
| AU (1) | AU2022281992A1 (https=) |
| BR (1) | BR112023023833A2 (https=) |
| CA (1) | CA3219960A1 (https=) |
| IL (1) | IL308530A (https=) |
| TW (1) | TW202313107A (https=) |
| WO (1) | WO2022248478A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120936347A (zh) * | 2023-04-14 | 2025-11-11 | 阿斯利康(瑞典)有限公司 | 非小细胞肺癌的治疗 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ628923A (en) | 2009-11-24 | 2016-02-26 | Medimmune Ltd | Targeted binding agents against b7-h1 |
| US20190276543A1 (en) * | 2018-03-08 | 2019-09-12 | Astrazeneca Pharmaceuticals Lp | Compositions and methods for treating late stage lung cancer |
| BR112022022304A2 (pt) * | 2020-05-04 | 2022-12-20 | Merck Sharp & Dohme Llc | Métodos para tratar câncer usando uma combinação de um antagonista pd-1, uma quimiorradioterapia e um inibidor de parp |
-
2022
- 2022-05-24 CA CA3219960A patent/CA3219960A1/en active Pending
- 2022-05-24 WO PCT/EP2022/064061 patent/WO2022248478A1/en not_active Ceased
- 2022-05-24 BR BR112023023833A patent/BR112023023833A2/pt not_active Application Discontinuation
- 2022-05-24 TW TW111119315A patent/TW202313107A/zh unknown
- 2022-05-24 EP EP22731132.1A patent/EP4347038A1/en active Pending
- 2022-05-24 AU AU2022281992A patent/AU2022281992A1/en not_active Abandoned
- 2022-05-24 KR KR1020237041378A patent/KR20240012413A/ko active Pending
- 2022-05-24 CN CN202280037041.0A patent/CN117425493A/zh active Pending
- 2022-05-24 IL IL308530A patent/IL308530A/en unknown
- 2022-05-24 US US18/560,527 patent/US20240254235A1/en active Pending
- 2022-05-24 JP JP2023571866A patent/JP2024521105A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102105152B (zh) | 包含cdks抑制剂和抗肿瘤剂的治疗组合 | |
| JP2003531129A5 (https=) | ||
| Kouroussis et al. | High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study | |
| JP2021518394A5 (https=) | ||
| WO2016180958A1 (en) | Treatment for multiple myeloma (mm) | |
| JP2019532970A5 (https=) | ||
| TW202207976A (zh) | 使用免疫檢查點抑制劑抗體治療癌症之方法和組合 | |
| CN115052628A (zh) | 抗pd-1抗体在治疗肿瘤中的用途 | |
| CN109806393B (zh) | 抗pd-1抗体、培美曲塞和铂类药物联合治疗非小细胞肺癌的用途 | |
| JP2021529777A5 (https=) | ||
| JP2021523096A5 (https=) | ||
| JPWO2021224499A5 (https=) | ||
| TW200306185A (en) | Combinations comprising EPOTHILONES and anti-metabolites | |
| JPWO2022248478A5 (https=) | ||
| WO2021213523A1 (zh) | 抗pd-1抗体和抗ctla-4抗体的组合在预防或治疗癌症中的用途 | |
| EP4583880A1 (en) | Compositions and methods for treating advanced solid tumors | |
| CN120752053A (zh) | 含抗tim-3抗体的药物组合 | |
| CN110013552B (zh) | 抗pd-1抗体、吉西他滨和铂类药物联合治疗恶性胆道肿瘤的用途 | |
| WO2024051670A1 (zh) | 结合tim-3的抗体与结合pd-1的抗体的药物组合 | |
| JPWO2020018789A5 (https=) | ||
| JPWO2021043955A5 (https=) | ||
| JPWO2022002153A5 (https=) | ||
| CN112543637B (zh) | 伊立替康联合免疫检查点抑制剂和5-fu在制备治疗肿瘤疾病的药物中的用途 | |
| JPWO2023056461A5 (https=) | ||
| IL311796A (en) | Anti-galectin-9 antibodies and their therapeutic uses |